My Portfolio
+
LINK YOUR PORTFOLIO

Evotec SE EVT-DE:XETRA

*Data is delayed | Exchange | EUR
Last | 06/03/26 CEST
5.03UNCH (UNCH)
Volume
320
52 week range
4.00 - 7.84
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.03
  • 52 Week High7.84
  • 52 Week High Date07/30/25
  • 52 Week Low4.00
  • 52 Week Low Date03/13/26

Latest On Evotec SE

Key Stats

  • Market Cap893.836M
  • Shares Out177.88M
  • 10 Day Average Volume0.76M
  • Dividend-
  • Dividend Yield-
  • Beta1.57

Latest On Evotec SE

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.03
  • 52 Week High7.84
  • 52 Week High Date07/30/25
  • 52 Week Low4.00
  • 52 Week Low Date03/13/26
  • Market Cap893.836M
  • Shares Out177.88M
  • 10 Day Average Volume0.76M
  • Dividend-
  • Dividend Yield-
  • Beta1.57

RATIOS/PROFITABILITY

  • EPS (TTM)-1.09
  • P/E (TTM)-4.62
  • Fwd P/E (NTM)-
  • EBITDA (TTM)24.848M
  • ROE (TTM)-24.06%
  • Revenue (TTM)745.039M
  • Gross Margin (TTM)11.47%
  • Net Margin (TTM)-26.02%
  • Debt To Equity (MRQ)55.38%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug...
Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Address
Essener Bogen 7
Hamburg
22419
Germany